Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
1998-10-22
pubmed:abstractText
Escherichia coli reporter strains modeling the high-level type A and B vancomycin resistances of Enterococcus faecium BM4147 and Ent. faecalis have been developed to study the respective VanR-VanS two-component regulatory systems. PvanH-, PvanRa-, PvanY-, and PvanRb-lacZ fusions report on expression from the vancomycin-resistant enterococci promoters of the type A vanRSHAXYZ and type B vanRSYWHBX gene clusters. These strains also express from single-copy chromosomal genes vanRa, vanRb, or vanRSb behind their respective promoter (PvanRa or PvanRb) or vanSa or vanSb behind the rhamnose-inducible PrhaB. Results show that activation (phosphorylation) of the response regulator VanRa by its sensor kinase VanSa leads to transcriptional activation of both PvanH and PvanRa. Additionally, VanRb activates its cognate promoters PvanY and PvanRb, although this occurs only in the absence of VanSb and presumably is caused by VanRb phosphorylation by an unidentified endogenous E. coli kinase. Thus, VanSb interferes with activation of VanRb, probably by acting as a phospho-VanRb phosphatase. Although both VanRa and VanRb activate their cognate promoters, neither activates the heterologous PvanR, PvanH, or PvanY, arguing against the interchangeability of type A and B two-component regulatory switches in vancomycin-resistant enterococci. VanRa also is activated by the nonpartner kinase PhoR. Because this occurs in the absence of its inducing signal (Pi limitation), PhoR autophosphorylation apparently is regulated in vivo. Furthermore, the activation of VanRa caused by cross talk from PhoR in the absence of a signal allows distinction of cross talk from crossregulation as the latter, but not the former, responds to environmental cues.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-11902729, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-1551826, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-1551836, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-1556077, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-2137119, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-2523687, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-2824439, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-2968517, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-3555840, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-3596251, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-7559459, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8037690, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8146133, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8161518, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8215264, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8494882, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8631706, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8664263, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8693022, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8809744, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8899716, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8962056, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-8981985, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-9177243, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-9294159, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-9294451, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-9454587, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-9495769, http://linkedlifedata.com/resource/pubmed/commentcorrection/9751771-9560273
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
29
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11951-6
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:9751771-Anti-Bacterial Agents, pubmed-meshheading:9751771-Bacterial Proteins, pubmed-meshheading:9751771-Base Sequence, pubmed-meshheading:9751771-DNA Primers, pubmed-meshheading:9751771-Drug Resistance, Microbial, pubmed-meshheading:9751771-Enterococcus, pubmed-meshheading:9751771-Enterococcus faecalis, pubmed-meshheading:9751771-Enterococcus faecium, pubmed-meshheading:9751771-Escherichia coli, pubmed-meshheading:9751771-Gene Expression, pubmed-meshheading:9751771-Genes, Bacterial, pubmed-meshheading:9751771-Genes, Reporter, pubmed-meshheading:9751771-Lac Operon, pubmed-meshheading:9751771-Models, Biological, pubmed-meshheading:9751771-Phosphorylation, pubmed-meshheading:9751771-Polymerase Chain Reaction, pubmed-meshheading:9751771-Promoter Regions, Genetic, pubmed-meshheading:9751771-Protein Kinases, pubmed-meshheading:9751771-Signal Transduction, pubmed-meshheading:9751771-Transcription Factors, pubmed-meshheading:9751771-Vancomycin
pubmed:year
1998
pubmed:articleTitle
In vivo characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in Escherichia coli: a nonpathogenic model for studying the VRE signal transduction pathways.
pubmed:affiliation
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't